The Enterprise Value as of December 2024 (TTM) for ProPhase Labs, Inc. (PRPH) is 44.22M

According to ProPhase Labs, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 44.22M. This represents a change of -58.18% compared to the average of 105.75M of the last 4 quarters.

ProPhase Labs, Inc. (PRPH) Historical Enterprise Value (quarterly & annually)

How has PRPH Enterprise Value performed in the past?

The mean historical Enterprise Value of ProPhase Labs, Inc. over the last ten years is 64.48M. The current 44.22M Enterprise Value has changed 6.76% with respect to the historical average. Over the past ten years (40 quarters), PRPH's Enterprise Value was at its highest in in the June 2022 quarter at 226.73M. The Enterprise Value was at its lowest in in the March 2017 quarter at -4023860.00.

ProPhase Labs, Inc. (PRPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ProPhase Labs, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ProPhase Labs, Inc. (PRPH) Average Enterprise Value

How has PRPH Enterprise Value performed in the past?

The current Enterprise Value of ProPhase Labs, Inc. (PRPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ProPhase Labs, Inc. (PRPH) Enterprise Value vs. Peers

How is PRPH’s Enterprise Value compared to its peers?

ProPhase Labs, Inc.’s Enterprise Value is less than LumiraDx Limited (301.24M), greater than Star Equity Holdings, Inc. (19.63M), greater than Enzo Biochem, Inc. (-5986122.00), greater than Genetron Holdings Limited (0), less than Neuronetics, Inc. (70.48M), greater than Intelligent Bio Solutions Inc. (2.70M), less than Biodesix, Inc. (244.39M), greater than Precipio, Inc. (7.94M), greater than DarioHealth Corp. (38.72M), less than Olink Holding AB (publ) (3.16B), less than Exagen Inc. (88.54M), less than Sotera Health Company (5.83B), less than Burning Rock Biotech Limited (75.67M), greater than Psychemedics Corporation (15.91M), less than Sera Prognostics, Inc. (280.54M),

Build a custom stock screener for ProPhase Labs, Inc. (PRPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProPhase Labs, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProPhase Labs, Inc. (PRPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProPhase Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.